Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01294-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Yaqi Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuh…. Hauptthemen laut MEDLINE: Apoptosis, Flavanones, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Liquiritigenin (LQ), as a dihydroflavone monomer compound extracted from Glycyrrhiza uralensis Fisch, has been demonstrated to show anti-tumor effects in multiple human cancers, including lung adenocarcinoma. Our study aimed to explore its role in lung squamous cell carcinoma (LSCC) development and the related mechanism. The effects of LQ on SK-MES-1 and NCI-H520 cell proliferation, cell cycle, and apoptosis were investigated. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and colony formation assays revealed that LQ inhibited LSCC cell viability and proliferation in a dose- and time-dependent manner. Flow cytometry analysis demonstrated that LQ promoted G2/M cell cycle arrest, cell apoptosis, and loss of mitochondrial membrane potential. In vivo assays showed that LQ administration suppressed tumor growth in nude mice. Additionally, LQ treatment reduced the levels of phosphorylated PI3K, AKT, and mTOR levels in LSCC cells. Pretreatment with the PI3K inhibitor LY294002 antagonized the LQ-mediated effects on cell proliferation, cell cycle arrest, and apoptosis in LSCC cells. Collectively, LQ induces cell cycle arrest and apoptosis in LSCC by inactivating the PI3K/AKT/mTOR pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China.
- Department of Dermatology, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, 430014, China.
- Department of Traditional Chinese Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430014, China. guomx87@hotmail.com.
Zitieren
APA
Liu, Y., Wang, Y., Yang, Y., Quan, Y., & Guo, M. (2024). Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01294-w
Vancouver
Liu Y, Wang Y, Yang Y, Quan Y, Guo M. Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01294-w
BibTeX
@article{Liu2024,
author = {Liu, Yaqi and Wang, Yixiao and Yang, Yiran and Quan, Yihong and Guo, Mingxing},
title = {Liquiritigenin Induces Cell Cycle Arrest and Apoptosis in Lung Squamous Cell Carcinoma},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01294-w}
}
EUVIMED